Darren Keamy - Realord Group Insider

Realord Group Holdings Limited -- Germany Stock  

EUR 0.62  0.00  0.00%

CFO, Company Secretary

Mr. Darren M. Keamy, BComm, CPA, serves as Company Secretary and Chief Financial Officer of Clinuvel Pharmaceuticals Ltd. He is Certified Practicing Accountant, joined Clinuvel Pharmaceuticals Limited November 2005 and became Chief Financial Officer of the Company in 2006.
  CFO Since 2006  CPA    

Management Efficiency

The company has return on total asset (ROA) of (1.97) % which means that it has lost $1.97 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of 8.71 % meaning that it generated $8.71 on every $100 dollars invested by stockholders.
The company has accumulated 75.95 M in total debt with debt to equity ratio (D/E) of 57.6 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Realord Group Holdings Limited has Current Ratio of 1.22 suggesting that it is in a questionable position to pay out its financial obligations in time and when they become due.

Similar Executives

Found 1 records

CFO Since

Ruth PoratAlphabet Inc
N/A

Entity Summary

Realord Group Holdings Limited (CUV) is traded on Frankfurt Stock Exchange in Germany. and employs 7 people.
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Realord Group Holdings Limited to your portfolio

Top Management

Realord Group Holdings Leadership Team
Willem Blijdorp, Director
Elie Ishag, Director
Stanley McLiesh, Chairman
Philippe Wolgen, CEO, MBA
Darren Keamy, CFO, CPA
Dennis Wright, President
Brenda Shanahan, Director

Stock Performance

Realord Group Performance Indicators